Biểu đồ giá cổ phiếu 06998.HK
EDDING GENOR (06998.HK)
Edding Genor Group Holdings Limited
HK$2.62
-7.42%
$-0.2
Thị trường chính thức: May 13, 10:03:56 HKT
Quay lại
Edding Genor Group Holdings Limited (06998.HK)
Thống kê chính
Giá đóng cửa trước
$2.75
Giá mở cửa
$2.83
Phạm vi ngày
$2.62 - $2.84
Phạm vi 52 tuần
$2.25 - $3.64
Khối lượng
1.2M
Khối lượng trung bình
2.0M
Tỷ suất cổ tức
--
EPS (TTM)
0.07
Vốn hóa thị trường
$5.2B
EDDING GENOR là gì?
Genor Biopharma Holdings Ltd. engages in the development and commercialization of oncology and autoimmune drugs. The company is headquartered in Shanghai, Shanghai and currently employs 17 full-time employees. The company went IPO on 2020-10-07. The Company’s main business is engaged in the discovery, development and commercialization of biopharmaceutical products for human use. The Company’s product pipelines include Lerociclib (GB491), GB261, GB263T, Infliximab (GB242), Coprelotamab (GB221), GB223, Rituximab (GB241), Vancocin, Ceclor and other products, covering disease fields such as breast cancer, lung cancer, gastrointestinal tumors, and blood tumors. The firm mainly conducts its business in the domestic market.
